Novavax has shipped 3.2 million doses of its COVID vaccine following its Centers for Disease Control and Prevention endorsement. Health officials hope the new shot, which does not use mRNA technology, will fill a gap in the U.S. vaccination push. (NBC News)

The head of the Food and Drug Administration has asked for a review of the agency’s food and tobacco programs. Dr. Robert Califf requested a reevaluation of food and tobacco operations after controversies surrounding the agency’s handling of baby formula shortage and e-cigarette reviews. (Associated Press)

Senate health chair Patty Murray has expressed concern with the country’s response to monkeypox. She said she believes the U.S. may be repeating the mistakes of the COVID-19 pandemic. (The Hill)

A federal report found that overdose deaths by Black people increased during the first year of the pandemic. The Centers for Disease Control and Prevention said fatal overdoses among Black people rose 44%, twice the increase of white people (22%) and Hispanic people (21%). (The New York Times)

After much delay, COVID nasal sprays and tablet vaccines are under development. Immunologists are working towards manufacturing nasal sprays and oral pills to prevent illness. (CNN)